1. Shiomi T, Noguchi T, Nakayama H, et al. Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depth. J Eur Acad Dermatol Venereol 2013;27:589-92.
2. Kang Z, Xu F, Zhang QA, et al. Oncogenic mutations in extramammary Paget's disease and their clinical relevance. Int J Cancer 2013;132:824-31.
3. Kakizaki A, Fujimura T, Furudate S, et al. Immunomodulatory effect of peritumorally administered interferon-beta on melanoma through tumor- associated macrophages. Oncoimmunology 2015;4:e1047584.
4. Fujimura T, Kambayashi Y, Hidaka T, Hashimoto A, Haga T, Aiba S. Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease. Acta Derm Venereol 2012;92:625-8.
5. Kambayashi Y, Fujimura T, Aiba S. Comparison of immunosuppressive and immunomodulatory cells in keratoacanthoma and cutaneous squamous cell carcinoma. Acta Derm Venereol 2013;93:663-8.
6. Kambayashi Y, Fujimura T, Furudate S, Hashimoto A, Haga T, Aiba S. Comparison of immunosuppressive and cytotoxic cells in angiosarcoma: development of a possible supportive therapy for angiosarcoma. Dermatology 2013;227:14-20.
7. Kambayashi Y, Fujimura T, Furudate S, Asano M, Kakizaki A, Aiba S. The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages. J Invest Dermatol 2015;135:2547-50.
8. Fujimura T, Kambayashi Y, Furudate S, Asano M, Kakizaki A, Aiba S. Receptor Activator of NF-kappaB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages. J Invest Dermatol 2015;135:2884-7.
9. Furudate S, Fujimura T, Tsukada A, et al. Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab. Case Rep Oncol 2017;10:52-6.
10. Hidaka T, Fujimura T, Aiba S. Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers. Front Med (Lausanne) 2019;6:194.
11. Vlachos C, Schulte BM, Magiatis P, Adema GJ, Gaitanis G. Malassezia- derived indoles activate the aryl hydrocarbon receptor and inhibit Toll- like receptor-induced maturation in monocyte-derived dendritic cells. Br J Dermatol 2012;167:496-505.
12. Kolluri SK, Jin UH, Safe S. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target. Arch Toxicol 2017;91:2497-513.
13. Chang JT, Chang H, Chen PH, Lin SL, Lin P. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clin Cancer Res 2007;13:38-45.
14. Agostinis P, Garmyn M, Laethem AV. The Aryl Hydrocarbon Receptor: An Illuminating Effector of the UVB Response. 2007.
15. Villano CM, Murphy KA, Akintobi A, White LA. 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol Appl Pharmacol 2006;210:212-24.
16. Findley K, Oh J, Yang J, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature 2013;498:367-70.
17. Gemmer CM, DeAngelis YM, Theelen B, Boekhout T, Dawson TL, Jr. Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J Clin Microbiol 2002;40:3350-7.
18. Cabanes FJ. Malassezia yeasts: how many species infect humans and animals? PLoS Pathog 2014;10:e1003892.
19. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL, Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004;51:785-98.
20. Ashbee HR. Update on the genus Malassezia. Med Mycol 2007;45:287- 303.
21. Tajima M, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol 2008;128:345-51.
22. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007;25:606-15.
23. Darabi K, Hostetler SG, Bechtel MA, Zirwas M. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol 2009;60:125-36.
24. Barac A, Pekmezovic M, Milobratovic D, Otasevic-Tasic S, Radunovic M, Arsic Arsenijevic V. Presence, species distribution, and density of Malassezia yeast in patients with seborrhoeic dermatitis - a community- based case-control study and review of literature. Mycoses 2015;58:69-75.
25. Furue M, Takahara M, Nakahara T, Uchi H. Role of AhR/ARNT system in skin homeostasis. Arch Dermatol Res 2014;306:769-79.
26. Magiatis P, Pappas P, Gaitanis G, et al. Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin. J Invest Dermatol 2013;133:2023-30.
27. Gaitanis G, Magiatis P, Stathopoulou K, et al. AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. J Invest Dermatol 2008;128:1620-5.
28. Hidaka T, Ogawa E, Kobayashi EH, et al. The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nat Immunol 2017;18:64-73.
29. Hong CH, Lee CH, Yu HS, Huang SK. Benzopyrene, a major polyaromatic hydrocarbon in smoke fume, mobilizes Langerhans cells and polarizes Th2/17 responses in epicutaneous protein sensitization through the aryl hydrocarbon receptor. Int Immunopharmacol 2016;36:111-7.
30. Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008;453:65-71.
31. Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008;453:106-9.
32. Brockmann L, Giannou AD, Gagliani N, Huber S. Regulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis. Int J Mol Sci 2017;18.
33. Benevides L, da Fonseca DM, Donate PB, et al. IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment. Cancer Res 2015;75:3788-99.
34. Chen KJ, Lin SZ, Zhou L, et al. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One 2011;6:e24671.
35. Liu J, Zhang N, Li Q, et al. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One 2011;6:e19495.
36. Lee SK, Park K-K, Kim H-J, et al. Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis. Sci Rep 2017;7.
37. Marsigliante S, Vetrugno C, Muscella A. Paracrine CCL20 loop induces epithelial-mesenchymal transition in breast epithelial cells. Mol Carcinog 2016;55:1175-86.
38. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009;31:331-41.
39. Qian X, Gu L, Ning H, et al. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. J Immunol 2013;190:5894-902.
40. Langowski JL, Zhang X, Wu L, et al. IL-23 promotes tumour incidence and growth. Nature 2006;442:461-5.
41. Sheng S, Zhang J, Ai J, Hao X, Luan R. Aberrant expression of IL- 23/IL-23R in patients with breast cancer and its clinical significance. Mol Med Rep 2018;17:4639-44.
42. Zhang Q, Liu S, Parajuli KR, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene 2017;36:687-99.
43. Fujimura T, Sato Y, Kambayashi Y, et al. Three patients with advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and chemokine (C-X-C motif) ligand 10 as possible biomarkers predicting the biological behaviour of angiosarcoma. Br J Dermatol 2018;179:1392-5.
44. Fujimura T, Sato Y, Tanita K, et al. Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma. Front Oncol 2018;8:530.
45. Grycova A, Doricakova A, Dvorak Z. Impurities contained in antifungal drug ketoconazole are potent activators of human aryl hydrocarbon receptor. Toxicol Lett 2015;239:67-72.
46. Furudate S, Fujimura T, Kakizaki A, et al. The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides. Exp Dermatol 2016;25:107-12.
47. Nastase MV, Zeng-Brouwers J, Beckmann J, et al. Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol 2018;68-69:293-317.
48. Peng D, Kryczek I, Nagarsheth N, et al. Epigenetic silencing of TH1- type chemokines shapes tumour immunity and immunotherapy. Nature 2015;527:249-53.
49. McAleer JP, Kolls JK. Directing traffic IL‐17 and IL‐22 coordinate pulmonary immune defense. Immunol Rev 2014;260:129-44.
50. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129:311- 21.
51. Brembilla NC, Senra L, Boehncke WH. The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond. Front Immunol 2018;9:1682.
52. Dainichi T, Kabashima K. Interaction of Psoriasis and Bullous Diseases. Front Med (Lausanne) 2018;5:222.
53. Kambayashi Y, Fujimura T, Furudate S, et al. The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin. Anticancer Res 2018;38:113-20.
54. Sparber F, De Gregorio C, Steckholzer S, et al. The Skin Commensal Yeast Malassezia Triggers a Type 17 Response that Coordinates Anti-fungal Immunity and Exacerbates Skin Inflammation. Cell Host Microbe 2019;25:389-403 e6.
55. Li N, Yamasaki K, Saito R, et al. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36gamma induction in human epidermal keratinocytes. J Immunol 2014;193:5140-8.
56. D'Erme AM, Wilsmann-Theis D, Wagenpfeil J, et al. IL-36gamma (IL- 1F9) is a biomarker for psoriasis skin lesions. J Invest Dermatol 2015;135:1025-32.
57. Balato A, Mattii M, Caiazzo G, et al. IL-36gamma Is Involved in Psoriasis and Allergic Contact Dermatitis. J Invest Dermatol 2016;136:1520- 3.
58. Pfaff CM, Marquardt Y, Fietkau K, Baron JM, Luscher B. The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function. Sci Rep 2017;7:15631.
59. Van Gorp H, Delputte PL, Nauwynck HJ. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol Immunol 2010;47:1650-60.